Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine

References

• SoulesMRShermanSParrottEExecutive summary: stages of reproductive aging workshop (STRAW)J Womens Health Gend Based Med200110984384811747678
   PubMedGoogle Scholar
• The North American Menopause SocietyEstrogen and progestogen use in postmenopausal women: 2010 position statement of the North American Menopause SocietyMenopause201017224225520154637
   PubMed Web of Science ®Google Scholar
• BlumelJEChedrauiPBaronGA large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-age womenMenopause201118777878521407137
   PubMed Web of Science ®Google Scholar
• PolitiMCSchleinitzMDColNFRevisiting the duration of vasomotor symptoms of menopause: a meta-analysisJ Gen Intern Med20082391507151318521690
   PubMed Web of Science ®Google Scholar
• ThurstonRCJoffeHVasomotor symptoms and menopause: findings from the Study of Women’s Health across the NationObstet Gynecol201138489501
   Web of Science ®Google Scholar
• GoldEBColvinAAvisNLongitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women’s health across the nationAm J Public Health20069671226123516735636
   PubMed Web of Science ®Google Scholar
• FordKSowersMCrutchfieldMWilsonAJannauschMA longitudinal study of the predictors of prevalence and severity of symptoms commonly associated with menopauseMenopause200512330831715879920
   PubMed Web of Science ®Google Scholar
• MelbyMKAndersonDSievertLLObermeyerCMMethods used in cross-cultural comparisons of vasomotor symptoms and their determinantsMaturitas201170211011921871743
   PubMed Web of Science ®Google Scholar
• BryantCJuddFKHickeyMAnxiety during the menopausal transition: a systematic reviewJ Affect Disord7212011 [Epub before print.]
   Web of Science ®Google Scholar
• DeecherDCDorriesKUnderstanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stagesArch Womens Ment Health20071024725718074100
   PubMed Web of Science ®Google Scholar
• RossmanithWGRuebberdtWWhat causes hot flashes? The neuroendocrine origin of vasomotor symptoms in the menopauseGynecol Endocrinol200925530331419903037
   PubMed Web of Science ®Google Scholar
• WalkerEMRodriquezAIKohnBAcupuncture versus venlafaxine for management of vasomotor symptoms in patients with hormone receptor positive breast cancer: a randomized, clinical trialJ Clin Oncol201028463464020038728
   PubMed Web of Science ®Google Scholar
• AvisNELegaultCCoeytauxRRA randomized, controlled pilot study of acupuncture treatment for menopausal hot flashesMenopause20081561070107818528313
   PubMed Web of Science ®Google Scholar
• ChoSHWhangWWAcupuncture for vasomotor menopausal symptoms: a systematic reviewMenopause20091651065107319424092
   PubMed Web of Science ®Google Scholar
• ElkinsGMarcusJStearnsVHasan RajabMPilot evaluation of hypnosis for the treatment of hot flashes in breast cancer survivorsPsychooncology200716548749217048223
   PubMed Web of Science ®Google Scholar
• ElkinsGMarcusJStearnsVRandomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivorsJ Clin Oncol200826315022502618809612
   PubMed Web of Science ®Google Scholar
• The North American Menopause SocietyTreatment of menopause-associated vasomotor symptoms: position statement of the North American Menopause SocietyMenopause2004111113314716179
   PubMed Web of Science ®Google Scholar
• DaleyAMacArthurCMutrieNExercise for vasomotor menopausal symptomsCochrane Database Syst Rev20074CD00610817943886
   PubMed Web of Science ®Google Scholar
• ThackerHLAssessing risks and benefits of nonhormonal treatments for vasomotor symptoms in perimenopausal and postmenopausal womenJ Womens Health201120710071016
   Web of Science ®Google Scholar
• KronenbergFFugh-BermanAComplementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trialsAnn Intern Med20021371080581312435217
   PubMed Web of Science ®Google Scholar
• ShamsTSetiaMSHemmingsRMcCuskerJSewitchMCiampiAEfficacy of black cohosh-containing preparations on menopausal symptoms: a meta-analysisAltern Ther Health Med2010161364420085176
   PubMed Web of Science ®Google Scholar
• BaiWHenneicke-von ZepelinHHWangSEfficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tiboloneMaturitas2007581314117587516
   PubMed Web of Science ®Google Scholar
• PockajBAGallagherJGLoprinziCLPhase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1J Clin Oncol200624182836284116782922
   PubMed Web of Science ®Google Scholar
• GellerSEShulmanLPvan BreemenRBSafety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trialMenopause20091661156116619609225
   PubMed Web of Science ®Google Scholar
• NaserBSchnitkerJMinkinMJde ArribaSGNolteKUOsmersRSuspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extractMenopause201118436637521228727
   PubMed Web of Science ®Google Scholar
• UebelhackRBlohmerJUGraubaumHJBuschRGruenwaldJWerneckeKDBlack cohosh and St John’s wort for climacteric complaints: a randomized trialObstet Gynecol200610724725516449108
   PubMed Web of Science ®Google Scholar
• StomatiMMonteleonePCasarosaESix-month oral dehydroepiandrosterone supplementation in early and late postmenopauseGynecol Endocrinol200014534236311109974
   PubMed Web of Science ®Google Scholar
• ChenoyRHussainSTayobYO’BrienPMMossMYMorsePFEffect of oral gamolenic acid from evening primrose oil on menopausal flushingBMJ199430869275015038136666
   PubMed Web of Science ®Google Scholar
• St GermainAPetersonCTRobinsonJGAlekelDLIsoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatmentMenopause200181172611201510
   PubMed Web of Science ®Google Scholar
• NelsonHDVescoKKHaneyENonhormonal therapies for menopausal hot flashes: systematic review and meta-analysisJAMA2006295172057207116670414
   PubMed Web of Science ®Google Scholar
• KrebsEEEnsrudKEMacDonaldRWiltTJPhytoestrogens for treatment of menopausal symptoms: a systematic reviewObstet Gynecol2004104482483615458907
   PubMed Web of Science ®Google Scholar
• TakuKMelbyMKKronenbergFKurzerMSMessinaMExtracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trialsMenopause3192012 [Epub before print.]
   Web of Science ®Google Scholar
• TiceJAEttingerBEnsrudKWallaceRBlackwellTCummingsSRPhytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trialJAMA2003290220721412851275
   PubMed Web of Science ®Google Scholar
• LewisJENickellLAThompsonLUSzalaiJPKissAHilditchJRA randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopauseMenopause200613463164216837885
   PubMed Web of Science ®Google Scholar
• BartonDLLoprinziCLQuellaSKProspective evaluation of vitamin E for hot flashes in breast cancer survivorsJ Clin Oncol19981624955009469333
   PubMed Web of Science ®Google Scholar
• MacLennanAHBroadbentJLLesterSMooreVOral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushesCochrane Database Syst Rev20044CD00297815495039
   PubMedGoogle Scholar
• RossouwJEAndersonGLPrenticeRLRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trialJAMA2002288332133312117397
   PubMed Web of Science ®Google Scholar
• Livial (tibolone) [package insert]Cambridge, MAOrganon Laboratories2006
   Google Scholar
• ModelskaKCummingsSTibolone for postmenopausal women: systematic review of randomized trialsJ Clin Endocrinol Metab2002871162311788614
   PubMed Web of Science ®Google Scholar
• BeralVBreast cancer and hormone-replacement therapy in the Million Women StudyLancet2003362938241942712927427
   PubMed Web of Science ®Google Scholar
• KenemansPBundredNJFoidartJMSafety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trialLancet Oncol200910213514619167925
   PubMed Web of Science ®Google Scholar
• ArcherDFTissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptomsDrugs Aging201027753354420583848
   PubMed Web of Science ®Google Scholar
• PickarJHYehITBachmanGEndometrial effects of a tissue selective estrogen complex (TSEC) containing bazedoxifene/conjugated estrogens as a menopausal therapyFertil Steril200992101018102419635613
   PubMed Web of Science ®Google Scholar
• GoldbergRMLoprinziCLO’FallonJRTransdermal clonidine for ameliorating tamoxifen-induced hot flashesJ Clin Oncol19941211551588270972
   PubMed Web of Science ®Google Scholar
• PandyaKJRaubertasRFFlynnPJOral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program studyAnn Intern Med20001321078879310819701
   PubMed Web of Science ®Google Scholar
• GuttusoTKurlanRMcDermottMPKieburtzKGabapentin’s effects on hot flashes in postmenopausal women: a randomized controlled trialObstet Gynecol2003101233734512576259
   PubMed Web of Science ®Google Scholar
• PandyaKJMorrowGRRoscoeJAGabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trialLancet2005366948881882416139656
   PubMed Web of Science ®Google Scholar
• ReddySYWarnerHGuttusoTGabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trialObstet Gynecol20061081414816816054
   PubMed Web of Science ®Google Scholar
• PachmanDRJonesJMLoprinziCLManagement of menopause-associated vasomotor symptoms: current treatment options, challenges and future directionsInt J Women’s Health20102123135
   PubMedGoogle Scholar
• LoprinziCLQinRBalcuevaEPPhase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1J Clin Oncol201028464164719901102
   PubMed Web of Science ®Google Scholar
• StearnsVBeebeKLLyengarMDubeEParoxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trialJAMA2003289212827283412783913
   PubMed Web of Science ®Google Scholar
• StearnsVSlackRGreepNParoxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trialJ Clin Oncol200523286919693016192581
   PubMed Web of Science ®Google Scholar
• BartonDLLaVasseurBSloanJAA phase III trial evaluating three doses of citalopram for hot flashes: NCCTG trial N05C9J Clin Oncol201028203278328320498389
   PubMed Web of Science ®Google Scholar
• FreemanEWGuthrieKACaanBEfficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trialJAMA2011305326727421245182
   PubMed Web of Science ®Google Scholar
• LoprinziCLSloanJAPerezEAPhase III evaluation of fluoxetine for treatment of hot flashesJ Clin Oncol20022061578158311896107
   PubMed Web of Science ®Google Scholar
• KimmickGGLovatoJMcQuellonRRobinsonEMussHBRandomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifenBreast J200612211412216509835
   PubMed Web of Science ®Google Scholar
• GordonPRKerwinJPBoesenKGSenfJSertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general populationMenopause200613456857516837878
   PubMed Web of Science ®Google Scholar
• JoffeHSoaresCNPetrilloLFTreatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetineJ Clin Psychiatry200768694395017592922
   PubMed Web of Science ®Google Scholar
• LoprinziCLKuglerJWSloanJAVenlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trialLancet200035692472059206311145492
   PubMed Web of Science ®Google Scholar
• LoprinziCLLevittRBartonDPhase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7J Clin Oncol20062491409141416505409
   PubMed Web of Science ®Google Scholar
• DeecherDCAlfinitoPDLeventhalLAlleviation of thermoregulatory dysfunction with the new serotonin and norepinephrine reuptake inhibitor desvenlafaxine succinate in ovariectomized rodent modelsEndocrinology200714831376138317122073
   PubMed Web of Science ®Google Scholar
• SperoffLGassMConstantineGOlivierSEfficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trialObstet Gynecol20081111778718165395
   PubMed Web of Science ®Google Scholar
• ArcherDFDupontCMConstantineGDPickarJHOlivierSDesvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safetyAm J Obstet Gynecol20092003238. e1238. e1019167693
   PubMed Web of Science ®Google Scholar
• ArcherDFSeidmanLConstantineGDPickarJHOlivierSA double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopauseAm J Obstet Gynecol20092002172. e1172. e1019110224
   PubMed Web of Science ®Google Scholar
• BouchardPPanayNde VilliersTJRandomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptomsClimacteric2012151122022066790
   PubMed Web of Science ®Google Scholar
• GallagherJCStrzinekRAChengRFAusmanasMKAstlDSeljanPThe effect of dose titration and dose tapering on the tolerability of desvenlafaxine in women with vasomotor symptoms associated with menopauseJ Womens Health2012212188198
   Web of Science ®Google Scholar